Impact of PRR11 Expression on Prognosis in Pancreatic Cancer Patients with Diabetes

Area of Science:

• Oncology
• Endocrinology
• Biochemistry

Background:

• Diabetes mellitus and pancreatic cancer often co-occur, presenting complex clinical challenges.
• Understanding molecular markers that link these conditions is crucial for improved patient outcomes.

Purpose of the Study:

• To investigate the association between PRR11 protein expression and prognosis in patients with both diabetes mellitus and pancreatic cancer.
• To explore the relationship between PRR11 expression, glycemic control, and survival rates.

Main Methods:

• Immunohistochemical staining was used to assess PRR11 protein levels in pancreatic cancer tissues from 70 patients.
• Patients were categorized based on diabetes mellitus status and glycemic control.
• Survival analysis was performed to evaluate the prognostic significance of PRR11 expression.

Main Results:

• PRR11 expression was significantly higher in pancreatic cancer patients with diabetes mellitus compared to those without.
• PRR11 levels positively correlated with markers of poor glycemic control, including fasting blood glucose, total cholesterol, triglycerides, and HbA1c.
• Patients with positive PRR11 expression exhibited significantly lower survival rates.

Conclusions:

• Positive PRR11 protein expression is linked to a poor prognosis in patients with diabetes mellitus and pancreatic cancer.
• PRR11 may serve as a potential predictive biomarker and therapeutic target for pancreatic cancer, particularly in diabetic patients.
• Further research into PRR11's functional mechanisms is needed to guide personalized treatment strategies.